Moving from Clinical Trial Operations to Study Design: How Foundations of Clinical Research Elevated Samuel Okafor’s Expertise

For Samuel Okafor, PharmD, a clinical research professional with more than four years of experience in global clinical trial operations, advancing in the field has meant continuously expanding both scope and perspective. His work has spanned Phase I to Phase III clinical trials in immunology, neurology, oncology devices, the central nervous system, ophthalmology, and infectious diseases.

Okafor began his career as a clinical research coordinator and progressed into clinical research associate roles, conducting site initiation, interim monitoring, and close-out visits across U.S. and international studies. 

As his responsibilities grew, he became deeply involved in protocol compliance review, safety documentation assessment, and trial master file (TMF) reconciliation in alignment with good clinical practice (GCP) standards and International Council for Harmonisation (ICH) guidelines. In 2024, his contributions were recognized when he received the Clinical Researcher of the Year Global Gold Award in the PharmaTimes Americas competition.

Alongside his work in clinical trial operations, Okafor founded LunaClinical, where he provides independent clinical research oversight. He is also the founder and CEO of LunaVax, a vaccine innovation initiative focused on advancing equitable access through microneedle vaccine patches, biometric-enabled immunization systems, and local manufacturing models in Africa. 

Identifying the Need for Deeper Clinical Research Training

Despite his operational experience in clinical trials, Okafor recognized a gap in his formal training. “After several years in clinical trial monitoring, I sought deeper formal training in study design, biostatistics, and regulatory science,” he explains. “While I understood how trials operated in practice, I wanted stronger academic grounding in how they are designed, powered, and analyzed.”

He was particularly interested in strengthening his understanding of endpoint selection, statistical interpretation, and protocol development to complement his operational experience in clinical trials. 

Seeking a program that emphasized methodological rigor and real-world application, Okafor applied and was accepted to the Foundations of Clinical Research certificate program at Harvard Medical School.

Putting Deeper Scientific Reasoning into Practice

 During Foundations of Clinical Research, Okafor gained the analytical framework he had been seeking while maintaining his professional responsibilities through the program’s fully virtual format. The structured focus on study design and biostatistics reshaped how he approached his monitoring and oversight responsibilities, shifting his attention from procedural execution to deeper scientific reasoning. 

“The program significantly strengthened my analytical perspective,” he says. “It improved how I interpret protocols, amendments, and data trends.”

Okafor applies this knowledge daily through more substantive protocol interpretation, informed risk assessment, and rigorous data evaluation during monitoring activities. Rather than focusing solely on compliance, he approaches each study with a clearer understanding of the scientific rationale behind design decisions.

Instead of viewing statistics as isolated calculations, Okafor now sees them as essential tools for evaluating study validity and clinical relevance. “The biostatistics modules were particularly impactful, as they strengthened my ability to interpret logistic regression outputs and confidence intervals in practical contexts,” he notes. The applied assignments, paired with structured faculty feedback, pushed him to move from theory to execution and enhanced his analytical precision.

A Research Project Grounded in Real-World Data

A defining component of Foundations of Clinical Research is the individual research project, which requires participants to apply the principles of study design, biostatistics, and data interpretation to a structured analysis. The project challenges learners to move from concept to execution, selecting variables, defining outcomes, and conducting appropriate statistical analyses.

For Okafor, this meant designing a retrospective cohort study using publicly available data from India to examine twin pregnancy as a predictor of preterm birth. The study required the consideration of outcome definition, covariate selection, and the use of multivariate logistic regression to evaluate predictors within the dataset.

“The project reinforced the importance of careful variable selection, confounding assessment, and responsible statistical interpretation in drawing clinically meaningful conclusions,” Okafor explains.

Advancing Innovation Through a Global Perspective

In his work with LunaVax, Okafor is advancing the design of a phased vaccine pilot integrating microneedle technology and biometric verification systems, principles of study design, statistical validity, and ethical oversight guide each decision. “The methodological foundation from the program has allowed me to translate innovation concepts into research frameworks that are ethically sound, statistically valid, and implementation ready,” he says.

Equally influential was the global learning environment, which enabled Okafor to engage with clinicians, researchers, and industry professionals from diverse backgrounds. “The collaborative discussions during workshops were especially memorable,” he reflects. “Seeing how global perspectives shaped study design discussions enriched the academic experience far beyond textbook learning.”

Together, these experiences reshaped how he sees his role within clinical research. “Professionally, it elevated my confidence in engaging sponsors and investigators at a higher level of scientific dialogue,” Okafor says. “I transitioned from executing study procedures to thinking more like a study designer.”